Reagents and methods for analysis of HIV
AssigneeSiemens Healthcare Diagnostics Inc.
InventorsSunil Pandit, Arejas Uzgiris, Lance Palmer
Life of this patent
Estimating the term…
Loading patent…
AssigneeSiemens Healthcare Diagnostics Inc.
InventorsSunil Pandit, Arejas Uzgiris, Lance Palmer
Estimating the term…
The present invention is based in part on the present inventors' appreciation that certain sequences within an HIV genome are more likely to successfully detect HIV across a breadth of HIV variants. The ability to detect and/or quantify the presence and/or load of HIV in a subject is important to, among other things, the diagnosis and treatment of infected individuals. The present invention is based, in part, on the discovery of oligonucleotide reagents that detectably amplify sequences from a greater breadth of HIV samples than certain prior reagents and/or that generate amplicons from HIV genomes from which certain prior reagents would not have generated amplicons. Oligonucleotide reagents as described herein provide unexpected benefits in the detection and/or quantification of the presence and/or load of HIV in a subject, and thereby in the diagnosis and treatment of HIV.
A composition comprising a pair of oligonucleotide primers and at least one probe,
A composition that is an amplification reaction mixture, the composition comprising:
A kit comprising:
A composition comprising:
Dependencies are inferred from the claim text.